Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy of XXB750 and Drug Combination for Patients with Heart Failure
ItalyStudy on the Safety and Effects of Livmoniplimab and Budigalimab in Patients with Advanced or Metastatic Solid Tumors
ItalyStudy on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis
ItalyStudy on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
ItalyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
ItalyLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
ItalyStudy on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)
ItalyStudy on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
ItalyStudy on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease
ItalyStudy of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup
ItalyLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
